Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer. [electronic resource]
Producer: 20160824Description: 205-15 p. digitalISSN:- 2589-0409
- Animals
- Antibodies, Monoclonal -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Disease Models, Animal
- Drug Resistance, Neoplasm -- radiation effects
- Drug Synergism
- Gene Dosage
- Gene Expression Regulation, Neoplastic
- Genes, bcl-2
- Humans
- Male
- Mice
- Prostatic Neoplasms -- genetics
- Radiotherapy
- TNF-Related Apoptosis-Inducing Ligand -- genetics
- Transcription, Genetic
- Tumor Stem Cell Assay
- Xenograft Model Antitumor Assays
- bcl-2-Associated X Protein -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.